First year of the CAT: one advanced therapy approved, but more to come
This article was originally published in RAJ Devices
Executive Summary
As the European Medicines Agency celebrates the 15th anniversary of its creation in January 1995, its Committee on Advanced Therapies has marked its first year of operations by reviewing progress in developing the European Union regulatory framework for these novel medicines1.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.